Tag: Breast-cancer
-
Understanding pathology behind triple negative breast cancer
A study conducted at the Research Institute of the McGill University Health Centre (RI-MUHC) suggests screening breast cancer patients for the prolactin receptor could improve the prognosis for patient and may help them avoid unnecessary and invasive treatments. Using a database of 580 women with triple negative breast cancer (TNBC), the researchers found that survival…
-
Tamoxifen and Aromatase Inhibitor therapies linked to reduced risk for contralateral breast cancer in community health
In patients with invasive breast cancer treated in a general community health care setting, Tamoxifen, Aromatase Inhibitor therapies linked to reduced risk for contralateral breast cancer in community and that risk progressively decreased as the duration of tamoxifen therapy increased, according to a new study published online by JAMA Oncology. About 5 percent of patients…
-
Improving participation in cancer screening should be a priority
Early diagnosis of cancer is linked to better survival rates. Unfortunately, participation rates for cancer screening worldwide are low even when screening programmes are free. The ESMO 2016 Congress is showcasing five studies (1) on this important area of cancer management which look at alternative ways to overcome barriers and improve screening rates Professor J-F…
-
Neoadjuant PARP inhibitor treatment shrinks tumors in BRCA-positive breast cancer patients
All 13 newly diagnosed breast cancer patients with BRCA mutations had their tumors shrink significantly when treated with a PARP inhibitor ahead of frontline presurgical chemotherapy in a pilot study at The University of Texas MD Anderson Cancer Center. Results of the study (abstract 153PD) will be presented Saturday at a breast cancer poster discussion…
Medical News Observer 